IVF clinics that lie about success rates could be taken to court under new legal guidance
Clinics could face enforcement action if they fail to make clear the costs of treatments
10 June 2021 • 6:00am
IVF clinics that lie about success rates could be taken to court by couples, as the first legal guidance for fertility treatment is published.
The Competition and Markets Authority (CMA), the competition regulator, drew up the groundbreaking guidance with the Human Fertilisation and Embryology Authority (HFEA).
It warns that clinics could face enforcement action if they are unclear about how successful fertility treatment may be, or if they fail to make costs of different treatments clear to customers.
The CMA has published new guidance to make clear clinics’ legal obligations to treat people fairly and to help IVF patients understand their consumer rights.
Tinkering with embryos up to a limit of 14 days is wrong What happens when the limit vanishes? » MercatorNet mercatornet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mercatornet.com Daily Mail and Mail on Sunday newspapers.
Book Review: CRISPR People – The science and ethics of editing humans
Appeared in BioNews 1097
In November 2018, the Chinese scientist Dr He Jiankui announced to attendees of the second International Summit on Human Genome Editing that he had used CRISPR-based genome editing to alter the DNA of embryos before transferring them into their mother s uterus. According to Dr He, twin girls with edits to their
CCR5gene – known to be implicated in HIV infection – had been born in China just one month prior to the conference.
As far as the scientific community was concerned, this experiment came far too soon, both in terms of regard for the scientific safety and efficacy of what Dr He was trying to achieve, but also within the framework of bioethics. In his new book CRISPR People, Henry T Greely, professor of law at Stanford University, California, describes the science, ethics and legality of using genome editing to make genetic modifications in humans that will be inherited b
EXCLUSIVE - When we got Hudson s diagnosis, it was like someone had punched us in the stomach : British tech tycoon tells of heartbreaking battle to solve mystery of son s illness
Callum and Nikki McKeefery knew something wasn t right with their baby son Hudson when he reached six months old
At that stage Hudson had very weak muscle tone was still unable to support his head or to reach or roll over
What followed was a heartbreaking three-year fight to discover what was wrong with their little boy
After seeing many different mystified consultants, he was eventually diagnosed with an extremely rare genetic condition called FDXR